These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ý
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
|
¨
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
|
90-0199783
|
|
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
|
100 Potrero Avenue
San Francisco, CA
|
|
94103-4813
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 1.
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
Condensed Consolidated Statements of Comprehensive Income
for the Fiscal Quarters and Fiscal Year-to-date Periods Ended June 28, 2013 and June 29, 2012
|
|
|
|
|
|
|
|
Condensed Consolidated Statements of Stockholders' Equity for the Fiscal
Year-to-date Periods Ended June 28, 2013 and June 29, 2012
|
|
|
|
|
|
|
|
Condensed Consolidated Statements of Cash Flows for the Fiscal
Year-to-date Periods Ended June 28, 2013 and June 29, 2012
|
|
|
|
|
|
|
|
||
|
|
|
|
|
Item 2.
|
||
|
|
|
|
|
Item 3.
|
||
|
|
|
|
|
Item 4.
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 1.
|
||
|
|
|
|
|
Item 1A.
|
||
|
|
|
|
|
Item 2.
|
||
|
|
|
|
|
Item 6.
|
||
|
|
|
|
|
|
June 28,
2013 |
September 28,
2012 |
||||
|
ASSETS
|
|
|
||||
|
Current assets:
|
|
|
||||
|
Cash and cash equivalents
|
$
|
408,561
|
|
$
|
492,600
|
|
|
Short-term investments
|
109,342
|
|
302,693
|
|
||
|
Accounts receivable, net of allowance of $758 at June 28, 2013 and $956 at September 28, 2012
|
74,528
|
|
43,495
|
|
||
|
Inventories
|
12,795
|
|
16,700
|
|
||
|
Deferred taxes
|
79,114
|
|
80,966
|
|
||
|
Prepaid expenses and other current assets
|
30,200
|
|
33,832
|
|
||
|
Total current assets
|
714,540
|
|
970,286
|
|
||
|
Long-term investments
|
335,371
|
|
361,614
|
|
||
|
Property, plant and equipment, net
|
245,667
|
|
254,676
|
|
||
|
Intangible assets, net
|
44,736
|
|
56,526
|
|
||
|
Goodwill
|
278,718
|
|
281,375
|
|
||
|
Deferred taxes
|
36,591
|
|
22,634
|
|
||
|
Other non-current assets
|
11,827
|
|
13,687
|
|
||
|
Total assets
|
$
|
1,667,450
|
|
$
|
1,960,798
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
||||
|
Current liabilities:
|
|
|
||||
|
Accounts payable
|
$
|
8,845
|
|
$
|
14,831
|
|
|
Accrued liabilities
|
119,154
|
|
116,092
|
|
||
|
Income taxes payable
|
1,012
|
|
2,424
|
|
||
|
Deferred revenue
|
23,233
|
|
23,493
|
|
||
|
Total current liabilities
|
152,244
|
|
156,840
|
|
||
|
Long-term deferred revenue
|
19,073
|
|
18,192
|
|
||
|
Deferred taxes
|
—
|
|
2,696
|
|
||
|
Other non-current liabilities
|
46,271
|
|
39,837
|
|
||
|
Total liabilities
|
217,588
|
|
217,565
|
|
||
|
Stockholders’ equity:
|
|
|
||||
|
Class A common stock, $0.001 par value, one vote per share, 500,000,000 shares authorized: 46,735,504 shares issued and outstanding at June 28, 2013 and 46,496,635 at September 28, 2012
|
47
|
|
46
|
|
||
|
Class B common stock, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 54,997,311 shares issued and outstanding at June 28, 2013 and 56,598,829 at September 28, 2012
|
55
|
|
57
|
|
||
|
Additional paid-in capital
|
17,111
|
|
—
|
|
||
|
Retained earnings
|
1,408,587
|
|
1,709,479
|
|
||
|
Accumulated other comprehensive income
|
5,812
|
|
10,687
|
|
||
|
Total stockholders’ equity – Dolby Laboratories, Inc.
|
1,431,612
|
|
1,720,269
|
|
||
|
Controlling interest
|
18,250
|
|
22,964
|
|
||
|
Total stockholders’ equity
|
1,449,862
|
|
1,743,233
|
|
||
|
Total liabilities and stockholders’ equity
|
$
|
1,667,450
|
|
$
|
1,960,798
|
|
|
|
Fiscal Quarter Ended
|
Fiscal Year-to-Date Ended
|
||||||||||
|
|
June 28,
2013 |
June 29,
2012 |
June 28,
2013 |
June 29,
2012 |
||||||||
|
Revenue:
|
|
|
|
|||||||||
|
Licensing
|
$
|
184,707
|
|
$
|
180,886
|
|
$
|
616,038
|
|
$
|
609,159
|
|
|
Products
|
17,381
|
|
22,132
|
|
60,605
|
|
75,760
|
|
||||
|
Services
|
4,986
|
|
7,304
|
|
16,379
|
|
22,340
|
|
||||
|
Total revenue
|
207,074
|
|
210,322
|
|
693,022
|
|
707,259
|
|
||||
|
Cost of revenue:
|
|
|
|
|
||||||||
|
Cost of licensing
|
4,053
|
|
2,892
|
|
13,542
|
|
9,523
|
|
||||
|
Cost of products
|
16,269
|
|
14,529
|
|
47,964
|
|
46,052
|
|
||||
|
Cost of services
|
4,018
|
|
3,610
|
|
11,722
|
|
9,458
|
|
||||
|
Total cost of revenue
|
24,340
|
|
21,031
|
|
73,228
|
|
65,033
|
|
||||
|
Gross margin
|
182,734
|
|
189,291
|
|
619,794
|
|
642,226
|
|
||||
|
Operating expenses:
|
|
|
|
|
||||||||
|
Research and development
|
42,915
|
|
35,123
|
|
127,299
|
|
102,185
|
|
||||
|
Sales and marketing
|
58,528
|
|
49,269
|
|
175,079
|
|
138,779
|
|
||||
|
General and administrative
|
38,413
|
|
36,859
|
|
123,324
|
|
109,605
|
|
||||
|
Restructuring charges/(credits)
|
5,930
|
|
(85
|
)
|
5,930
|
|
1,193
|
|
||||
|
Total operating expenses
|
145,786
|
|
121,166
|
|
431,632
|
|
351,762
|
|
||||
|
Operating income
|
36,948
|
|
68,125
|
|
188,162
|
|
290,464
|
|
||||
|
Interest income
|
820
|
|
1,513
|
|
3,063
|
|
4,664
|
|
||||
|
Interest expense
|
(77
|
)
|
(26
|
)
|
(504
|
)
|
(57
|
)
|
||||
|
Other income, net
|
156
|
|
709
|
|
1,057
|
|
969
|
|
||||
|
Income before income taxes
|
37,847
|
|
70,321
|
|
191,778
|
|
296,040
|
|
||||
|
Provision for income taxes
|
(7,345
|
)
|
(18,915
|
)
|
(47,560
|
)
|
(82,951
|
)
|
||||
|
Net income including controlling interest
|
30,502
|
|
51,406
|
|
144,218
|
|
213,089
|
|
||||
|
Less: net (income)/loss attributable to controlling interest
|
(286
|
)
|
123
|
|
(742
|
)
|
(281
|
)
|
||||
|
Net income attributable to Dolby Laboratories, Inc.
|
$
|
30,216
|
|
$
|
51,529
|
|
$
|
143,476
|
|
$
|
212,808
|
|
|
Net income per share:
|
|
|
|
|
||||||||
|
Basic
|
$
|
0.30
|
|
$
|
0.48
|
|
$
|
1.41
|
|
$
|
1.97
|
|
|
Diluted
|
$
|
0.29
|
|
$
|
0.48
|
|
$
|
1.39
|
|
$
|
1.96
|
|
|
Weighted-average shares outstanding:
|
|
|
|
|
||||||||
|
Basic
|
101,751
|
|
106,328
|
|
101,917
|
|
107,876
|
|
||||
|
Diluted
|
103,031
|
|
107,202
|
|
102,999
|
|
108,493
|
|
||||
|
Related party rent expense included in operating expenses
|
$
|
1,494
|
|
$
|
343
|
|
$
|
2,180
|
|
$
|
1,029
|
|
|
Related party rent expense included in net income attributable to controlling interest
|
$
|
831
|
|
$
|
732
|
|
$
|
2,467
|
|
$
|
2,118
|
|
|
|
Fiscal Quarter Ended
|
Fiscal Year-to-Date Ended
|
||||||||||
|
|
June 28,
2013 |
June 29,
2012 |
June 28,
2013 |
June 29,
2012 |
||||||||
|
Net income including controlling interest
|
$
|
30,502
|
|
$
|
51,406
|
|
$
|
144,218
|
|
$
|
213,089
|
|
|
Other comprehensive income/(loss):
|
|
|
|
|
||||||||
|
Foreign currency translation adjustments, net of tax
|
(2,008
|
)
|
(3,117
|
)
|
(3,878
|
)
|
(1,560
|
)
|
||||
|
Unrealized gains/(losses) on available-for-sale securities, net of tax
|
(852
|
)
|
(279
|
)
|
(1,414
|
)
|
(87
|
)
|
||||
|
Comprehensive income
|
27,642
|
|
48,010
|
|
138,926
|
|
211,442
|
|
||||
|
Less: comprehensive (income)/loss attributable to controlling interest
|
(388
|
)
|
286
|
|
(326
|
)
|
(270
|
)
|
||||
|
Comprehensive income attributable to Dolby Laboratories, Inc.
|
$
|
27,254
|
|
$
|
48,296
|
|
$
|
138,600
|
|
$
|
211,172
|
|
|
|
Dolby Laboratories, Inc.
|
|
|
||||||||||||||||||
|
|
Common stock
|
Additional
paid-in
capital
|
Retained
earnings
|
Accumulated
other
comprehensive
income
|
Total Dolby
Laboratories,
Inc.
|
Controlling
interest
|
Total
|
||||||||||||||
|
Balance at September 28, 2012
|
$
|
103
|
|
$
|
—
|
|
$
|
1,709,479
|
|
$
|
10,687
|
|
$
|
1,720,269
|
|
$
|
22,964
|
|
$
|
1,743,233
|
|
|
Net income
|
—
|
|
—
|
|
143,476
|
|
—
|
|
143,476
|
|
742
|
|
144,218
|
|
|||||||
|
Translation adjustments, net of taxes of $1,037
|
—
|
|
—
|
|
—
|
|
(3,461
|
)
|
(3,461
|
)
|
(417
|
)
|
(3,878
|
)
|
|||||||
|
Unrealized losses on available-for-sale securities, net of taxes of $793
|
—
|
|
—
|
|
—
|
|
(1,414
|
)
|
(1,414
|
)
|
—
|
|
(1,414
|
)
|
|||||||
|
Distributions to controlling interest
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
(5,039
|
)
|
(5,039
|
)
|
|||||||
|
Stock-based compensation expense
|
—
|
|
49,932
|
|
—
|
|
—
|
|
49,932
|
|
—
|
|
49,932
|
|
|||||||
|
Repurchase of common stock
|
(1
|
)
|
(37,979
|
)
|
(36,162
|
)
|
—
|
|
(74,142
|
)
|
—
|
|
(74,142
|
)
|
|||||||
|
Cash dividends declared and paid on common stock
|
—
|
|
—
|
|
(408,206
|
)
|
—
|
|
(408,206
|
)
|
—
|
|
(408,206
|
)
|
|||||||
|
Tax benefit/(deficiency) from stock incentive plans
|
—
|
|
(2,749
|
)
|
—
|
|
—
|
|
(2,749
|
)
|
—
|
|
(2,749
|
)
|
|||||||
|
Class A common stock issued under employee stock plans
|
—
|
|
13,313
|
|
—
|
|
—
|
|
13,313
|
|
—
|
|
13,313
|
|
|||||||
|
Shares repurchased for tax withholdings on vesting of restricted stock units
|
—
|
|
(5,709
|
)
|
—
|
|
—
|
|
(5,709
|
)
|
—
|
|
(5,709
|
)
|
|||||||
|
Exercise of Class B stock options
|
—
|
|
303
|
|
—
|
|
—
|
|
303
|
|
—
|
|
303
|
|
|||||||
|
Balance at June 28, 2013
|
$
|
102
|
|
$
|
17,111
|
|
$
|
1,408,587
|
|
$
|
5,812
|
|
$
|
1,431,612
|
|
$
|
18,250
|
|
$
|
1,449,862
|
|
|
|
Dolby Laboratories, Inc.
|
|
|
||||||||||||||||||
|
|
Common stock
|
Additional
paid-in
capital
|
Retained
earnings
|
Accumulated
other
comprehensive
income
|
Total Dolby
Laboratories,
Inc.
|
Controlling
interest
|
Total
|
||||||||||||||
|
Balance at September 30, 2011
|
$
|
110
|
|
$
|
210,681
|
|
$
|
1,445,189
|
|
$
|
7,533
|
|
$
|
1,663,513
|
|
$
|
21,837
|
|
$
|
1,685,350
|
|
|
Net income
|
—
|
|
—
|
|
212,808
|
|
—
|
|
212,808
|
|
281
|
|
213,089
|
|
|||||||
|
Translation adjustments, net of taxes of $(631)
|
—
|
|
—
|
|
—
|
|
(1,549
|
)
|
(1,549
|
)
|
(11
|
)
|
(1,560
|
)
|
|||||||
|
Unrealized losses on available-for-sale securities, net of taxes of $48
|
—
|
|
—
|
|
—
|
|
(87
|
)
|
(87
|
)
|
—
|
|
(87
|
)
|
|||||||
|
Distributions to controlling interest
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
(13
|
)
|
(13
|
)
|
|||||||
|
Stock-based compensation expense
|
—
|
|
33,721
|
|
—
|
|
—
|
|
33,721
|
|
—
|
|
33,721
|
|
|||||||
|
Capitalized stock-based compensation expense
|
—
|
|
338
|
|
—
|
|
—
|
|
338
|
|
—
|
|
338
|
|
|||||||
|
Repurchase of common stock
|
(5
|
)
|
(189,954
|
)
|
—
|
|
—
|
|
(189,959
|
)
|
—
|
|
(189,959
|
)
|
|||||||
|
Tax benefit/(deficiency) from stock incentive plans
|
—
|
|
(2,633
|
)
|
—
|
|
—
|
|
(2,633
|
)
|
—
|
|
(2,633
|
)
|
|||||||
|
Class A common stock issued under employee stock plans
|
—
|
|
16,117
|
|
—
|
|
—
|
|
16,117
|
|
—
|
|
16,117
|
|
|||||||
|
Shares repurchased for tax withholdings on vesting of restricted stock units
|
—
|
|
(3,380
|
)
|
—
|
|
—
|
|
(3,380
|
)
|
—
|
|
(3,380
|
)
|
|||||||
|
Exercise of Class B stock options
|
—
|
|
79
|
|
—
|
|
—
|
|
79
|
|
—
|
|
79
|
|
|||||||
|
Balance at June 29, 2012
|
$
|
105
|
|
$
|
64,969
|
|
$
|
1,657,997
|
|
$
|
5,897
|
|
$
|
1,728,968
|
|
$
|
22,094
|
|
$
|
1,751,062
|
|
|
|
Fiscal Year-to-Date Ended
|
|||||
|
|
June 28,
2013 |
June 29,
2012 |
||||
|
Operating activities:
|
|
|||||
|
Net income including controlling interest
|
$
|
144,218
|
|
$
|
213,089
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
||||
|
Depreciation and amortization
|
39,615
|
|
31,189
|
|
||
|
Stock-based compensation
|
49,932
|
|
34,243
|
|
||
|
Amortization of premium on investments
|
8,101
|
|
13,280
|
|
||
|
Excess tax benefit from exercise of stock options
|
(621
|
)
|
(941
|
)
|
||
|
Provision for doubtful accounts
|
(89
|
)
|
449
|
|
||
|
Deferred income taxes
|
(12,973
|
)
|
(7,075
|
)
|
||
|
Other non-cash items affecting net income
|
(800
|
)
|
38
|
|
||
|
Changes in operating assets and liabilities:
|
|
|
||||
|
Accounts receivable
|
(30,829
|
)
|
15,359
|
|
||
|
Inventories
|
5,636
|
|
5,275
|
|
||
|
Prepaid expenses and other assets
|
6,924
|
|
582
|
|
||
|
Accounts payable and other liabilities
|
(840
|
)
|
(1,567
|
)
|
||
|
Income taxes, net
|
(3,164
|
)
|
6,857
|
|
||
|
Deferred revenue
|
655
|
|
(221
|
)
|
||
|
Other non-current liabilities
|
1,723
|
|
2,441
|
|
||
|
Net cash provided by operating activities
|
207,488
|
|
312,998
|
|
||
|
Investing activities:
|
|
|
||||
|
Purchases of available-for-sale securities
|
(413,688
|
)
|
(431,894
|
)
|
||
|
Proceeds from sales of available-for-sale securities
|
534,109
|
|
261,520
|
|
||
|
Proceeds from maturities of available-for-sale securities
|
92,850
|
|
202,915
|
|
||
|
Purchases of property, plant and equipment
|
(17,801
|
)
|
(50,225
|
)
|
||
|
Acquisitions, net of cash acquired
|
—
|
|
(575
|
)
|
||
|
Other investments
|
(3,000
|
)
|
—
|
|
||
|
Purchases of intangible assets
|
(4,050
|
)
|
(350
|
)
|
||
|
Proceeds from sales of property, plant and equipment and assets held for sale
|
376
|
|
988
|
|
||
|
Net cash provided by/(used in) investing activities
|
188,796
|
|
(17,621
|
)
|
||
|
Financing activities:
|
|
|
||||
|
Proceeds from issuance of common stock
|
13,616
|
|
16,196
|
|
||
|
Repurchase of common stock
|
(74,142
|
)
|
(189,959
|
)
|
||
|
Payment of cash dividend
|
(408,206
|
)
|
—
|
|
||
|
Distribution to controlling interest
|
(5,039
|
)
|
—
|
|
||
|
Excess tax benefit from the exercise of stock options
|
621
|
|
941
|
|
||
|
Shares repurchased for tax withholdings on vesting of restricted stock
|
(5,709
|
)
|
(3,380
|
)
|
||
|
Net cash used in financing activities
|
(478,859
|
)
|
(176,202
|
)
|
||
|
Effect of foreign exchange rate changes on cash and cash equivalents
|
(1,464
|
)
|
(279
|
)
|
||
|
Net increase/(decrease) in cash and cash equivalents
|
(84,039
|
)
|
118,896
|
|
||
|
Cash and cash equivalents at beginning of period
|
492,600
|
|
551,512
|
|
||
|
Cash and cash equivalents at end of period
|
$
|
408,561
|
|
$
|
670,408
|
|
|
|
|
|
||||
|
Supplemental disclosure:
|
|
|
||||
|
Cash paid for income taxes, net of refunds received
|
$
|
64,155
|
|
$
|
83,185
|
|
|
Cash paid for interest
|
$
|
66
|
|
$
|
8
|
|
|
|
June 28,
2013 |
September 28,
2012 |
|
|
(in thousands)
|
|
|
Cash and cash equivalents:
|
|
|
|
Cash
|
$371,097
|
$468,622
|
|
Cash equivalents:
|
|
|
|
Money market funds
|
28,887
|
17,090
|
|
U.S. agency securities
|
7,070
|
—
|
|
Commercial paper
|
—
|
4,885
|
|
Corporate bonds
|
503
|
—
|
|
Municipal debt securities
|
1,004
|
2,003
|
|
Total cash and cash equivalents
|
408,561
|
492,600
|
|
Short-term investments:
|
|
|
|
U.S. agency securities
|
2,000
|
3,999
|
|
Commercial paper
|
2,987
|
19,414
|
|
Corporate bonds
|
49,664
|
107,243
|
|
Municipal debt securities
|
54,691
|
172,037
|
|
Total short-term investments
|
109,342
|
302,693
|
|
Long-term investments (1):
|
|
|
|
U.S. agency securities
|
44,861
|
21,013
|
|
Corporate bonds
|
103,345
|
112,993
|
|
Municipal debt securities
|
184,165
|
227,608
|
|
Other long-term investments (2)
|
3,000
|
—
|
|
Total long-term investments
|
335,371
|
361,614
|
|
Total cash, cash equivalents and investments
|
$853,274
|
$1,156,907
|
|
(1)
|
Our long-term investments have maturities that range from
one
to
three
years.
|
|
(2)
|
Other long-term investments include a
$3.0 million
investment made in the first quarter of fiscal
2013
, which we have accounted for under the cost method of accounting.
|
|
|
June 28, 2013
|
|||
|
|
Cost
|
Unrealized
Gains
|
Unrealized
Losses
|
Estimated Fair
Value
|
|
|
(in thousands)
|
|||
|
Money market funds
|
$28,887
|
$—
|
$—
|
$28,887
|
|
U.S. agency securities
|
54,061
|
17
|
(147)
|
53,931
|
|
Commercial paper
|
2,987
|
—
|
—
|
2,987
|
|
Corporate bonds
|
153,664
|
247
|
(399)
|
153,512
|
|
Municipal debt securities
|
240,108
|
248
|
(496)
|
239,860
|
|
Cash equivalents and investments (1)
|
$479,707
|
$512
|
$(1,042)
|
$479,177
|
|
(1)
|
Our investment portfolio of cash equivalents and investments exclude our
$3.0 million
cost method investment made in the first quarter of fiscal
2013
.
|
|
|
September 28, 2012
|
|||
|
|
Cost
|
Unrealized
Gains
|
Unrealized
Losses
|
Estimated Fair
Value
|
|
|
(in thousands)
|
|||
|
Money market funds
|
$17,090
|
$—
|
$—
|
$17,090
|
|
U.S. agency securities
|
24,997
|
18
|
(3)
|
25,012
|
|
Commercial paper
|
24,299
|
—
|
—
|
24,299
|
|
Corporate bonds
|
219,265
|
990
|
(19)
|
220,236
|
|
Municipal debt securities
|
400,958
|
728
|
(38)
|
401,648
|
|
Cash equivalents and investments
|
$686,609
|
$1,736
|
$(60)
|
$688,285
|
|
|
June 28, 2013
|
|||||
|
|
Less than 12 months
|
12 months or greater
|
Total
|
|||
|
|
Fair Value
|
Gross Unrealized Losses
|
Fair Value
|
Gross Unrealized Losses
|
Fair Value
|
Gross Unrealized Losses
|
|
|
(in thousands)
|
|||||
|
U.S. agency securities
|
$27,837
|
$(147)
|
$—
|
$—
|
$27,837
|
$(147)
|
|
Corporate bonds
|
86,140
|
(399)
|
—
|
—
|
86,140
|
(399)
|
|
Municipal debt securities
|
137,094
|
(496)
|
—
|
—
|
137,094
|
(496)
|
|
Total
|
$251,071
|
$(1,042)
|
$—
|
$—
|
$251,071
|
$(1,042)
|
|
|
September 28, 2012
|
|||||
|
|
Less than 12 months
|
12 months or greater
|
Total
|
|||
|
|
Fair Value
|
Gross Unrealized
Losses
|
Fair Value
|
Gross Unrealized
Losses
|
Fair Value
|
Gross Unrealized
Losses
|
|
|
(in thousands)
|
|||||
|
U.S. agency securities
|
$6,999
|
$(3)
|
$—
|
$—
|
$6,999
|
$(3)
|
|
Corporate bonds
|
25,277
|
(19)
|
—
|
—
|
25,277
|
(19)
|
|
Municipal debt securities
|
87,705
|
(37)
|
5,565
|
(1)
|
93,270
|
(38)
|
|
Total
|
$119,981
|
$(59)
|
$5,565
|
$(1)
|
$125,546
|
$(60)
|
|
|
June 28, 2013
|
September 28, 2012
|
||
|
|
Amortized Cost
|
Fair Value
|
Amortized Cost
|
Fair Value
|
|
|
(in thousands)
|
|||
|
Due within 1 year
|
$117,809
|
$117,919
|
$302,154
|
$302,693
|
|
Due in 1 to 2 years
|
176,210
|
176,258
|
209,302
|
209,871
|
|
Due in 2 to 3 years
|
156,801
|
156,113
|
151,174
|
151,743
|
|
Total
|
$450,820
|
$450,290
|
$662,630
|
$664,307
|
|
|
June 28,
2013 |
September 28,
2012 |
|
|
(in thousands)
|
|
|
Trade accounts receivable
|
$70,854
|
$43,565
|
|
Accounts receivable related to patent administration program
|
4,432
|
886
|
|
Accounts receivable, gross
|
75,286
|
44,451
|
|
Less: allowance for doubtful accounts
|
(758)
|
(956)
|
|
Accounts receivable, net
|
$74,528
|
$43,495
|
|
|
June 28,
2013 |
September 28,
2012 |
|
|
(in thousands)
|
|
|
Raw materials
|
$919
|
$4,403
|
|
Work in process
|
23
|
—
|
|
Finished goods
|
11,853
|
12,297
|
|
Inventories
|
$12,795
|
$16,700
|
|
|
June 28,
2013 |
September 28,
2012 |
|
|
(in thousands)
|
|
|
Prepaid assets
|
$9,196
|
$14,955
|
|
Other current assets
|
11,336
|
13,165
|
|
Income tax receivable
|
9,668
|
5,712
|
|
Prepaid expenses and other current assets
|
$30,200
|
$33,832
|
|
|
June 28,
2013 |
September 28,
2012 |
|
|
(in thousands)
|
|
|
Land
|
$48,039
|
$48,227
|
|
Buildings
|
33,185
|
27,266
|
|
Leasehold improvements
|
64,368
|
68,352
|
|
Machinery and equipment
|
36,539
|
29,070
|
|
Computer systems and software
|
89,953
|
86,266
|
|
Furniture and fixtures
|
13,400
|
13,158
|
|
Construction in progress
|
83,500
|
79,965
|
|
|
368,984
|
352,304
|
|
Less: accumulated depreciation
|
(123,317)
|
(97,628)
|
|
Property, plant and equipment, net
|
$245,667
|
$254,676
|
|
|
Total
|
|
|
(in thousands)
|
|
Balance at September 28, 2012
|
$281,375
|
|
Translation adjustments
|
(2,657)
|
|
Balance at June 28, 2013
|
$278,718
|
|
|
June 28, 2013
|
September 28, 2012
|
||||
|
|
Cost
|
Accumulated
Amortization
|
Net
|
Cost
|
Accumulated
Amortization
|
Net
|
|
Intangible assets subject to amortization:
|
(in thousands)
|
|||||
|
Acquired patents and technology
|
$79,338
|
$(48,351)
|
$30,987
|
$79,213
|
$(40,071)
|
$39,142
|
|
Customer relationships
|
30,690
|
(18,774)
|
11,916
|
30,679
|
(16,386)
|
14,293
|
|
Other intangibles
|
20,967
|
(19,134)
|
1,833
|
20,925
|
(17,834)
|
3,091
|
|
Total
|
$130,995
|
$(86,259)
|
$44,736
|
$130,817
|
$(74,291)
|
$56,526
|
|
Fiscal Year
|
Amortization Expense
|
|
|
(in thousands)
|
|
Remainder of 2013
|
$3,854
|
|
2014
|
13,619
|
|
2015
|
11,163
|
|
2016
|
8,993
|
|
2017
|
5,855
|
|
Thereafter
|
1,252
|
|
Total
|
$44,736
|
|
|
June 28,
2013 |
September 28,
2012 |
|
|
(in thousands)
|
|
|
Accrued royalties
|
$6,202
|
$2,391
|
|
Amounts payable to joint licensing program partners
|
39,774
|
35,492
|
|
Accrued compensation and benefits
|
43,855
|
47,331
|
|
Accrued professional fees
|
4,132
|
4,893
|
|
Other accrued liabilities
|
25,191
|
25,985
|
|
Accrued liabilities
|
$119,154
|
$116,092
|
|
|
June 28,
2013 |
September 28,
2012 |
|
|
(in thousands)
|
|
|
Supplemental retirement plan obligations
|
$2,147
|
$2,042
|
|
Non-current tax liabilities
|
25,827
|
20,862
|
|
Other liabilities
|
18,297
|
16,933
|
|
Other non-current liabilities
|
$46,271
|
$39,837
|
|
Level 1:
|
Quoted prices in active markets at the measurement date for identical assets and liabilities.
|
|
Level 2:
|
Prices may be based upon quoted prices in active markets or inputs not quoted on active markets but are corroborated by market data.
|
|
Level 3:
|
Unobservable inputs are used when little or no market data is available and reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability.
|
|
|
June 28, 2013
|
|||
|
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|
|
(in thousands)
|
|||
|
Assets:
|
|
|
|
|
|
Investments held in supplemental retirement plan (1)
|
$2,245
|
$—
|
$—
|
$2,245
|
|
Money market funds (2)
|
28,887
|
—
|
—
|
28,887
|
|
Commercial paper (3)
|
—
|
2,987
|
—
|
2,987
|
|
Corporate bonds (2), (3), (4)
|
—
|
153,511
|
—
|
153,511
|
|
Municipal debt securities (2), (3), (4)
|
—
|
239,860
|
—
|
239,860
|
|
U.S. agency securities (2), (3), (4)
|
53,931
|
—
|
—
|
53,931
|
|
Total
|
$85,063
|
$396,358
|
$—
|
$481,421
|
|
(1)
|
These assets are included within prepaid expenses and other current assets and within other non-current assets.
|
|
(2)
|
These assets are included within cash and cash equivalents.
|
|
(3)
|
These assets are included within short-term investments.
|
|
(4)
|
These assets are included within long-term investments.
|
|
|
June 28, 2013
|
|||
|
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|
|
(in thousands)
|
|||
|
Liabilities:
|
|
|
|
|
|
Investments held in supplemental retirement plan (1)
|
$2,245
|
$—
|
$—
|
$2,245
|
|
Total
|
$2,245
|
$—
|
$—
|
$2,245
|
|
(1)
|
These liabilities are included within accrued liabilities and within other non-current liabilities.
|
|
|
September 28, 2012
|
|||
|
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|
|
(in thousands)
|
|||
|
Assets:
|
|
|
|
|
|
Investments held in supplemental retirement plan (1)
|
$2,140
|
$—
|
$—
|
$2,140
|
|
Money market funds (2)
|
17,090
|
—
|
—
|
17,090
|
|
Commercial paper (3)
|
—
|
24,299
|
—
|
24,299
|
|
Corporate bonds (4)
|
—
|
220,236
|
—
|
220,236
|
|
Municipal debt securities (2), (4)
|
—
|
401,648
|
—
|
401,648
|
|
U.S. agency securities (4)
|
25,012
|
—
|
—
|
25,012
|
|
Total
|
$44,242
|
$646,183
|
$—
|
$690,425
|
|
(1)
|
These assets are included within prepaid expenses and other current assets and within other non-current assets.
|
|
(2)
|
These assets are included within cash and cash equivalents.
|
|
(3)
|
These assets are included within short-term investments and within long-term investments.
|
|
|
September 28, 2012
|
|||
|
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|
|
(in thousands)
|
|||
|
Liabilities:
|
|
|
|
|
|
Investments held in supplemental retirement plan (1)
|
$2,140
|
$—
|
$—
|
$2,140
|
|
Total
|
$2,140
|
$—
|
$—
|
$2,140
|
|
(1)
|
These liabilities are included within accrued liabilities and within other non-current liabilities.
|
|
|
Fiscal Quarter Ended
|
Fiscal Year-to-Date Ended
|
||
|
|
June 28,
2013 (2) |
June 29,
2012 |
June 28,
2013 (2) |
June 29,
2012 |
|
|
(in thousands)
|
|||
|
Stock-based compensation:
|
|
|
|
|
|
Stock options (1)
|
$5,438
|
$5,047
|
$17,437
|
$17,101
|
|
Restricted stock units
|
10,967
|
5,235
|
29,826
|
16,379
|
|
Employee stock purchase plan
|
878
|
442
|
2,669
|
667
|
|
Stock appreciation rights
|
—
|
17
|
—
|
96
|
|
Total stock-based compensation
|
17,283
|
10,741
|
49,932
|
34,243
|
|
Benefit from income taxes
|
(5,143)
|
(3,268)
|
(15,053)
|
(10,759)
|
|
Total stock-based compensation, net of tax
|
$12,140
|
$7,473
|
$34,879
|
$23,484
|
|
(1)
|
Expense excludes
$0.4 million
in the fiscal year-to-date period ended
June 29, 2012
related to stock-based compensation which was capitalized to property, plant and equipment.
|
|
(2)
|
We also recognize a tax benefit from certain exercises of incentive stock options and shares issued under our ESPP which are not included in the table above. This benefit was
$0.2 million
and
$0.1 million
in the
third
quarter of fiscal
2013
and fiscal
2012
, and
$0.4 million
and
$0.2 million
in the fiscal year-to-date period ended
June 28, 2013
and
June 29, 2012
, respectively.
|
|
|
Fiscal Quarter Ended
|
Fiscal Year-to-Date Ended
|
||
|
|
June 28,
2013 |
June 29,
2012 |
June 28,
2013 |
June 29,
2012 |
|
|
(in thousands)
|
|||
|
Stock-based compensation expense was classified as follows:
|
|
|
|
|
|
Cost of products
|
$187
|
$158
|
$585
|
$503
|
|
Cost of services
|
84
|
57
|
308
|
174
|
|
Research and development
|
4,133
|
2,668
|
13,033
|
8,300
|
|
Sales and marketing
|
5,569
|
3,820
|
16,736
|
11,539
|
|
General and administrative
|
5,443
|
4,038
|
17,403
|
13,727
|
|
Restructuring
|
1,867
|
—
|
1,867
|
—
|
|
Total stock-based compensation expense
|
$17,283
|
$10,741
|
$49,932
|
$34,243
|
|
|
Shares
|
Weighted Average
Exercise Price
|
Weighted Average
Remaining
Contractual Life
|
Aggregate
Intrinsic
Value
|
|
|
(in thousands)
|
|
(in years)
|
(in thousands)
|
|
Options outstanding at September 28, 2012
|
4,622
|
$32.50
|
|
|
|
Grants (1)
|
2,313
|
30.25
|
|
|
|
Exercises
|
(313)
|
22.32
|
|
$3,326
|
|
Forfeitures and cancellations
|
(187)
|
41.02
|
|
|
|
Options outstanding at June 28, 2013
|
6,435
|
29.69
|
7.6
|
29,873
|
|
Options vested and expected to vest at June 28, 2013
|
6,181
|
29.65
|
7.6
|
28,981
|
|
Options exercisable at June 28, 2013
|
2,690
|
28.47
|
5.7
|
17,040
|
|
(1)
|
Includes the additional shares of our common stock issuable upon the exercise of those options subject to the equity award modification that occurred in the first quarter of fiscal
2013
in connection with the special cash dividend.
|
|
|
Fiscal Quarter Ended
|
Fiscal Year-to-Date Ended
|
||
|
|
June 28,
2013 |
June 29,
2012 |
June 28,
2013 |
June 29,
2012 |
|
Expected life (in years)
|
4.37
|
4.53
|
4.37
|
4.53
|
|
Risk-free interest rate
|
0.6%
|
0.6%
|
0.5%
|
0.7%
|
|
Expected stock price volatility
|
35.3%
|
41.5%
|
40.4%
|
44.0%
|
|
Dividend yield
|
—
|
—
|
—
|
—
|
|
|
Shares
|
Weighted Average
Grant Date
Fair Value
|
|
|
(in thousands)
|
|
|
Non-vested at September 28, 2012
|
2,572
|
$37.98
|
|
Granted
|
1,194
|
30.96
|
|
Vested
|
(552)
|
41.03
|
|
Forfeitures
|
(133)
|
36.90
|
|
Non-vested at June 28, 2013
|
3,081
|
34.76
|
|
|
Shares
Repurchased
|
Cost
(in thousands)
(1)
|
Average Price
Paid per Share
(2)
|
|
Repurchase activity for the fiscal quarter ended December 28, 2012
|
1,674,648
|
$53,956
|
$32.20
|
|
Repurchase activity for the fiscal quarter ended March 29, 2013
|
382,481
|
11,477
|
$29.99
|
|
Repurchase activity for the fiscal quarter ended June 28, 2013
|
250,000
|
8,709
|
$34.82
|
|
Total
|
2,307,129
|
$74,142
|
|
|
(1)
|
Cost of share repurchases includes the price paid per share and applicable commissions.
|
|
(2)
|
Excludes commission costs.
|
|
|
Severance and associated
costs |
Facilities and
contract termination costs |
Total
|
||||||
|
|
(in thousands)
|
||||||||
|
Restructuring charges
|
4,779
|
|
1,151
|
|
5,930
|
|
|||
|
Cash payments
|
(1,670
|
)
|
—
|
|
(1,670
|
)
|
|||
|
Non-cash restructuring charges
|
(1,867
|
)
|
—
|
|
(1,867
|
)
|
|||
|
Balance at June 28, 2013
|
$
|
1,242
|
|
$
|
1,151
|
|
$
|
2,393
|
|
|
|
Fiscal Quarter End
|
Fiscal Year-to-Date Ended
|
||
|
|
June 28,
2013 |
June 29,
2012 |
June 28,
2013 |
June 29,
2012 |
|
|
(in thousands, except per share amounts)
|
|||
|
Numerator:
|
|
|
|
|
|
Net income attributable to Dolby Laboratories, Inc.
|
$30,216
|
$51,529
|
$143,476
|
$212,808
|
|
Denominator:
|
|
|
|
|
|
Weighted-average shares outstanding—basic
|
101,751
|
106,328
|
101,917
|
107,876
|
|
Potential common shares from options to purchase Class A and Class B common stock
|
307
|
577
|
293
|
496
|
|
Potential common shares from restricted stock units
|
972
|
297
|
790
|
121
|
|
Weighted-average shares outstanding—diluted
|
103,031
|
107,202
|
102,999
|
108,493
|
|
Net income per share attributable to Dolby Laboratories, Inc.—basic
|
$0.30
|
$0.48
|
$1.41
|
$1.97
|
|
Net income per share attributable to Dolby Laboratories, Inc.—diluted
|
$0.29
|
$0.48
|
$1.39
|
$1.96
|
|
Antidilutive options excluded from calculation
|
5,048
|
5,636
|
5,274
|
6,318
|
|
Antidilutive restricted stock units excluded from calculation
|
354
|
426
|
1,769
|
1,657
|
|
|
Payments Due By Fiscal Period
|
||||||
|
|
Remainder of Fiscal 2013
|
Fiscal
2014 |
Fiscal
2015 |
Fiscal
2016 |
Fiscal
2017 |
Thereafter
|
Total
|
|
|
(in thousands)
|
||||||
|
Naming rights
|
$—
|
$7,341
|
$7,432
|
$7,525
|
$7,619
|
$126,414
|
$156,331
|
|
Operating leases
|
4,140
|
14,305
|
9,076
|
6,424
|
4,706
|
5,783
|
44,434
|
|
Purchase obligations
|
2,992
|
2,535
|
1,372
|
212
|
18
|
—
|
7,129
|
|
Total
|
$7,132
|
$24,181
|
$17,880
|
$14,161
|
$12,343
|
$132,197
|
$207,894
|
|
•
|
We offer products, services, and technologies to creators and distributors of entertainment content, such as motion picture, television, and music recording studios, television broadcasters, satellite and cable operators, cinema theatre operators, and increasingly, Internet content streaming and download service providers. These content creators and distributors use our products, services, and technologies to encode and transmit content, creating rich, clear, and immersive audio experiences for consumers upon playback.
|
|
•
|
We license technologies, such as Dolby Digital, Dolby Digital Plus, and Dolby TrueHD to OEMs and software vendors for incorporation into their consumer entertainment, mobile, and other products, so that consumers can play back audio content with our technologies in the rich, clear, and immersive manner the creators intended.
|
|
•
|
We work directly with standards-setting organizations in the entertainment and technology industries, as well as governments and other regulatory bodies, to promote adoption of our technologies in their standards. As a result, our technologies are included in a majority of worldwide TV shipments to support digital TV standards in regions around the world. Our technologies are also included in virtually all DVD players, Blu-ray Disc players, audio/video receivers, and personal computer (“PC”) DVD software players.
|
|
|
Fiscal Quarter Ended
|
Fiscal Year-to-Date Ended
|
||
|
Revenue
|
June 28,
2013 |
June 29,
2012 |
June 28,
2013 |
June 29,
2012 |
|
Licensing
|
89%
|
86%
|
89%
|
86%
|
|
Products
|
8%
|
11%
|
9%
|
11%
|
|
Services
|
3%
|
3%
|
2%
|
3%
|
|
Total
|
100%
|
100%
|
100%
|
100%
|
|
|
Fiscal Quarter Ended
|
Fiscal Year-to-Date Ended
|
|
||
|
Market
|
June 28,
2013 |
June 29,
2012 |
June 28,
2013 |
June 29,
2012 |
Main Products Incorporating Our Technologies
|
|
Broadcast
|
38%
|
35%
|
37%
|
34%
|
Televisions and set-top boxes
|
|
PC
|
22%
|
30%
|
25%
|
28%
|
Microsoft Windows operating systems and DVD software players
|
|
Consumer Electronics
|
15%
|
18%
|
16%
|
19%
|
DVD and Blu-ray Disc players and recorders, audio/video receivers, and home-theater-in-a-box systems
|
|
Mobile
|
12%
|
7%
|
11%
|
8%
|
Smartphones, tablets and other mobile devices
|
|
Other
|
13%
|
10%
|
11%
|
11%
|
Video game consoles, Automotive (in-car DVD players)
|
|
Total
|
100%
|
100%
|
100%
|
100%
|
|
|
•
|
Purchasing trends away from traditional PCs and toward alternative devices without optical disc drives, such as ultrabooks and tablets, which may not include our technologies;
|
|
•
|
The prevalence of PC software that includes our technologies on an unauthorized and infringing basis, for which we receive no royalty payments; and
|
|
•
|
Continued decreasing inclusion of ISV media applications by PC OEMs in their Windows 7-based PCs, as Windows 7 already incorporates DVD playback software.
|
|
|
Fiscal Quarter Ended
|
Fiscal Year-to-Date Ended
|
||
|
Revenue
|
June 28,
2013 |
June 29,
2012 |
June 28,
2013 |
June 29,
2012 |
|
Broadcast
|
9%
|
11%
|
9%
|
11%
|
|
Cinema
|
87%
|
86%
|
87%
|
86%
|
|
Other
|
4%
|
3%
|
4%
|
3%
|
|
Total
|
100%
|
100%
|
100%
|
100%
|
|
|
Fiscal Quarter Ended
|
Change
|
Fiscal Year-to-Date Ended
|
Change
|
||||
|
|
June 28,
2013 |
June 29,
2012 |
$
|
%
|
June 28,
2013 |
June 29,
2012 |
$
|
%
|
|
|
($ in thousands)
|
($ in thousands)
|
||||||
|
Licensing
|
$184,707
|
$180,886
|
$3,821
|
2%
|
$616,038
|
$609,159
|
$6,879
|
1%
|
|
Percentage of total revenue
|
89%
|
86%
|
|
|
89%
|
86%
|
|
|
|
Products
|
17,381
|
22,132
|
(4,751)
|
(21)%
|
60,605
|
75,760
|
(15,155)
|
(20)%
|
|
Percentage of total revenue
|
8%
|
11%
|
|
|
9%
|
11%
|
|
|
|
Services
|
4,986
|
7,304
|
(2,318)
|
(32)%
|
16,379
|
22,340
|
(5,961)
|
(27)%
|
|
Percentage of total revenue
|
3%
|
3%
|
|
|
2%
|
3%
|
|
|
|
Total revenue
|
$207,074
|
$210,322
|
$(3,248)
|
(2)%
|
$693,022
|
$707,259
|
$(14,237)
|
(2)%
|
|
|
Fiscal Quarter Ended
|
Fiscal Year-to-Date Ended
|
||
|
|
June 28,
2013 |
June 29,
2012 |
June 28,
2013 |
June 29,
2012 |
|
|
($ in thousands)
|
|||
|
Cost of licensing
|
$4,053
|
$2,892
|
$13,542
|
$9,523
|
|
Licensing gross margin percentage
|
98%
|
98%
|
98%
|
98%
|
|
Cost of products
|
16,269
|
14,529
|
47,964
|
46,052
|
|
Products gross margin percentage
|
6%
|
34%
|
21%
|
39%
|
|
Cost of services
|
4,018
|
3,610
|
11,722
|
9,458
|
|
Services gross margin percentage
|
19%
|
51%
|
28%
|
58%
|
|
Total gross margin percentage
|
88%
|
90%
|
89%
|
91%
|
|
|
Fiscal Quarter Ended
|
Change
|
Fiscal Year-to-Date Ended
|
Change
|
||||
|
|
June 28,
2013 |
June 29,
2012 |
$
|
%
|
June 28,
2013 |
June 29,
2012 |
$
|
%
|
|
|
($ in thousands)
|
|||||||
|
Research and development
|
$42,915
|
$35,123
|
$7,792
|
22%
|
$127,299
|
$102,185
|
$25,114
|
25%
|
|
Percentage of total revenue
|
21%
|
17%
|
|
|
18%
|
14%
|
|
|
|
Sales and marketing
|
58,528
|
49,269
|
9,259
|
19%
|
175,079
|
138,779
|
36,300
|
26%
|
|
Percentage of total revenue
|
28%
|
23%
|
|
|
25%
|
20%
|
|
|
|
General and administrative
|
38,413
|
36,859
|
1,554
|
4%
|
123,324
|
109,605
|
13,719
|
13%
|
|
Percentage of total revenue
|
19%
|
18%
|
|
|
18%
|
15%
|
|
|
|
Restructuring charges/(credits)
|
5,930
|
(85)
|
6,015
|
7,076%
|
5,930
|
1,193
|
4,737
|
397%
|
|
Percentage of total revenue
|
3%
|
—%
|
|
|
1%
|
—%
|
|
|
|
|
$145,786
|
$121,166
|
$24,620
|
20%
|
$431,632
|
$351,762
|
$79,870
|
23%
|
|
|
Fiscal Quarter Ended
|
Change
|
Fiscal Year-to-Date Ended
|
Change
|
||||
|
|
June 28,
2013 |
June 29,
2012 |
$
|
%
|
June 28,
2013 |
June 29,
2012 |
$
|
%
|
|
|
($ in thousands)
|
|||||||
|
Interest income
|
$820
|
$1,513
|
$(693)
|
(46)%
|
$3,063
|
$4,664
|
$(1,601)
|
(34)%
|
|
Interest expense
|
(77)
|
(26)
|
(51)
|
196%
|
(504)
|
(57)
|
(447)
|
784%
|
|
Other income/(expense), net
|
156
|
709
|
(553)
|
(78)%
|
1,057
|
969
|
88
|
9%
|
|
Total other income, net
|
$899
|
$2,196
|
$(1,297)
|
(59)%
|
$3,616
|
$5,576
|
$(1,960)
|
(35)%
|
|
|
Fiscal Quarter Ended
|
Fiscal Year-to-Date Ended
|
||
|
|
June 28,
2013 |
June 29,
2012 |
June 28,
2013 |
June 29,
2012 |
|
|
($ in thousands)
|
|||
|
Provision for income taxes
|
$7,345
|
$18,915
|
$47,560
|
$82,951
|
|
Effective tax rate
|
19%
|
27%
|
25%
|
28%
|
|
|
June 28,
2013 |
September 28,
2012 |
|
|
(in thousands)
|
|
|
Cash and cash equivalents
|
$408,561
|
$492,600
|
|
Short-term investments
|
109,342
|
302,693
|
|
Long-term investments
|
335,371
|
361,614
|
|
Accounts receivable, net
|
74,528
|
43,495
|
|
Accounts payable and accrued liabilities
|
127,999
|
130,923
|
|
Working capital
(a)
|
562,296
|
813,446
|
|
|
|
|
|
|
Fiscal Year-to-Date Ended
|
|
|
|
June 28,
2013 |
June 29,
2012 |
|
|
(in thousands)
|
|
|
Net cash provided by operating activities
|
$207,488
|
$312,998
|
|
Capital expenditures
(b)
|
(17,801)
|
(50,225)
|
|
Repurchase of common stock
|
(74,142)
|
(189,959)
|
|
Net cash provided by/(used in) investing activities
|
188,796
|
(17,621)
|
|
Net cash used in financing activities
|
(478,859)
|
(176,202)
|
|
•
|
Purchasing trends away from traditional PCs and toward computing devices without optical disc drives, such as ultrabooks and tablets, which may not include our technologies;
|
|
•
|
The prevalence of PC software that includes our technologies on an unauthorized and infringing basis, for which we receive no royalty payments; and
|
|
•
|
Continued decreasing inclusion of ISV media applications by PC OEMs
|
|
•
|
Rapid technological change;
|
|
•
|
New and improved technology and frequent product introductions;
|
|
•
|
Changing consumer and licensee demands;
|
|
•
|
Evolving industry standards; and
|
|
•
|
Technology and product obsolescence.
|
|
•
|
We face risks that our customers maintain excess product inventory levels which could reduce future anticipated sales;
|
|
•
|
At least one of our competitors has exclusive licensing arrangements for 3D products with theater exhibitors, which has in the past and we expect will in the future restrict our ability to compete in the 3D market;
|
|
•
|
The 3D market has become increasingly competitive and we may lose further market share;
|
|
•
|
With the industry transition to 3D enabled screens substantially complete, demand for new 3D enabled screens has dropped significantly and the industry has entered into a replacement cycle;
|
|
•
|
Industry participants may perceive our up-front 3D equipment costs and reusable glasses business model or our 3D products as less attractive;
|
|
•
|
Our participation in the 3D cinema market will be limited to the extent that theaters do not convert from analog to digital cinema;
|
|
•
|
Demand for our 3D cinema products is driven by the number of 3D cinema releases and the commercial success of those releases;
|
|
•
|
Our 3D glasses could become subject to regulation in the U.S. and other countries in the future, which could restrict how our 3D glasses are manufactured, used, or marketed; and
|
|
•
|
There has been increased public scrutiny of potential health risks relating to viewing 3D movies. If these potential health risks are substantiated, the popularity of 3D movies could decline. In addition, if health risks associated with our 3D products materialize, we may become subject to government regulation or product liability claims, including personal injury claims.
|
|
•
|
Timing of receipt of royalty reports from our licensees and meeting revenue recognition criteria;
|
|
•
|
Royalty reports including positive or negative corrective adjustments;
|
|
•
|
Retroactive royalties that cover extended periods of time; and
|
|
•
|
The recognition of unusually large amounts of revenue in any given quarter because not all of our revenue recognition criteria were met in prior periods.
|
|
•
|
Exhibitors may perceive competing products to be advantageous to our products or they may choose lower priced competing products or competing products with different features;
|
|
•
|
At least one of our competitors has a significantly greater installed base of its digital cinema servers than we do, which has and likely will continue to limit our share of the digital cinema market, particularly in the U.S. market; and
|
|
•
|
Pricing and other competitive pressures have caused us to implement pricing strategies which have adversely affected gross margins of our products.
|
|
•
|
Diversion of management time and focus from operating our business to acquisition integration challenges;
|
|
•
|
Cultural and logistical challenges associated with integrating employees from acquired businesses into our organization;
|
|
•
|
Retaining employees, suppliers and customers from businesses we acquire;
|
|
•
|
The need to implement or improve internal controls, procedures, and policies appropriate for a public company at businesses that prior to the acquisition may have lacked effective controls, procedures, and policies;
|
|
•
|
Possible write-offs or impairment charges resulting from acquisitions;
|
|
•
|
Unanticipated or unknown liabilities relating to acquired businesses; and
|
|
•
|
The need to integrate acquired businesses’ accounting, management information, manufacturing, human resources, and other administrative systems to permit effective management.
|
|
•
|
Our ability to enforce our contractual and intellectual property rights, especially in those foreign countries that do not recognize and enforce intellectual property rights to the same extent as do the U.S., Japan, and European countries, which increases the risk of unauthorized, and uncompensated, use of our technologies;
|
|
•
|
Limited or no patent protection for our Dolby Digital technologies in countries such as China, Taiwan, and India, which may require us to obtain patent rights for new and existing technologies in order to grow or maintain our revenue;
|
|
•
|
Because of limitations in the legal systems in many countries, our ability to obtain and enforce patents in many countries is uncertain, and we must strengthen and develop relationships with entertainment industry participants worldwide to increase our ability to enforce our intellectual property and contractual rights without relying solely on the legal systems in the countries in which we operate;
|
|
•
|
U.S. and foreign government trade restrictions, including those which may impose restrictions on importation of programming, technology, or components to or from the U.S.;
|
|
•
|
Our ability to comply with applicable international laws and regulations governing our business and operations, including local consumer and safety laws, as well as license requirements;
|
|
•
|
Foreign government taxes, regulations, and permit requirements, including foreign taxes that we may not be able to offset against taxes imposed upon us in the U.S., and other laws limiting our ability to repatriate funds to the U.S.;
|
|
•
|
Burdens of complying with a variety of foreign laws;
|
|
•
|
Changes in diplomatic and trade relationships;
|
|
•
|
Difficulty in establishing, staffing, and managing foreign operations;
|
|
•
|
Adverse fluctuations in foreign currency exchange rates and interest rates, including risks related to any interest rate swap or other hedging activities we undertake;
|
|
•
|
Political or social instability, natural disasters, war or events of terrorism; and
|
|
•
|
The strength of international economies.
|
|
•
|
Fluctuations in demand for our products and for the digital entertainment products of our licensees;
|
|
•
|
Adverse developments in general economic conditions;
|
|
•
|
The amount and timing of our operating costs, capital expenditures, and related charges, including those related to the expansion or consolidation of our business, operations, and infrastructure;
|
|
•
|
Changes in business cycles that affect the markets in which we sell our products and services or the markets for consumer entertainment products incorporating our technologies;
|
|
•
|
Fluctuations in the timing of royalty reports we receive from our licensees, including late or sporadic reports;
|
|
•
|
Variations in the time-to-market of our technologies in the entertainment industry markets in which we operate;
|
|
•
|
Corrections to licensees’ reports received in periods subsequent to those in which the original revenue was reported;
|
|
•
|
The announcement, introduction, or enhancement of technologies, products, and services, by us, our licensees, and our competitors, and market acceptance of these new or enhanced technologies, products, and services;
|
|
•
|
Rapid, wholesale changes in technology in the entertainment industries in which we compete;
|
|
•
|
Events and conditions in the cinema industry, including box office receipts that affect the number of theaters constructed, the number of movies produced and exhibited, the general popularity of motion pictures, and strikes by cinema industry participants;
|
|
•
|
The financial resources of cinema exhibitors available to buy our products or to equip their theaters to accommodate upgraded or new technologies;
|
|
•
|
Consolidation by participants in the markets in which we compete, which could result among other things in pricing pressure;
|
|
•
|
Seasonal electronics product shipment patterns by our system licensees, particularly in our
second
fiscal quarter, which generally result in lower revenue in our
third
fiscal quarter;
|
|
•
|
The impact of, and our ability to react to, interruptions in the entertainment distribution process, including as a result of work stoppages at our facilities, our customers’ facilities, and other points throughout the entertainment distribution process;
|
|
•
|
Adverse outcomes of litigation or governmental proceedings, including any foreign, federal, state, or local tax assessments or audits;
|
|
•
|
Repurchases we make of our common stock;
|
|
•
|
Costs of litigation and intellectual property protection;
|
|
•
|
Exchange rate fluctuations between the U.S. dollar and other currencies;
|
|
•
|
Variations between our operating results and published analysts’ expectations; and
|
|
•
|
Announcements by our competitors or significant customers.
|
|
•
|
Earnings being lower than anticipated in countries that have lower tax rates and higher than anticipated in countries that have higher tax rates;
|
|
•
|
Changes in the valuation of our deferred tax assets and liabilities;
|
|
•
|
Expiration of or lapses in the R&D tax credit laws;
|
|
•
|
Fluctuations in tax exempt interest income;
|
|
•
|
Transfer pricing adjustments;
|
|
•
|
Tax effects of nondeductible compensation;
|
|
•
|
Tax costs related to intercompany realignments;
|
|
•
|
Changes in accounting principles; or
|
|
•
|
Changes in tax laws and regulations, including possible U.S. changes to the taxation of earnings of our foreign subsidiaries, the deductibility of expenses attributable to foreign income, or the foreign tax credit rules.
|
|
|
Total Number
of Shares Purchased |
Average Price
Paid per Share (1) |
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (2)
|
Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Programs (3)
|
|
March 30, 2013 - April 26, 2013
|
—
|
$—
|
—
|
$132.9 million
|
|
April 27, 2013 - May 24, 2013
|
137,000
|
34.33
|
137,000
|
$128.2 million
|
|
May 25, 2013 - June 28, 2013
|
113,000
|
35.41
|
113,000
|
$124.1 million
|
|
Total
|
250,000
|
|
250,000
|
|
|
(1)
|
Excludes commission costs.
|
|
(2)
|
Shares of Class A common stock were purchased under a
$250.0 million
stock repurchase program announced on
November 3, 2009
, which was subsequently increased by
$300.0 million
,
$250.0 million
, and
$100.0 million
announced on
July 27, 2010
,
August 4, 2011
, and
February 8, 2012
, respectively. The stock repurchase program does not have an expiration date. Stock repurchases under this program may be made through open market transactions, negotiated purchases, or otherwise, at times and in such amounts as we consider appropriate.
|
|
(3)
|
Amounts shown in this column reflect amounts remaining under the stock repurchase program.
|
|
|
|
Incorporated by Reference Herein
|
||
|
Exhibit
Number
|
Description
|
Form
|
Date
|
|
|
10.1
|
Amendment to Lease for 999 Brannan Street, San Francisco, California, dated June 27, 2013.
|
|
|
|
|
31.1
|
Certification by the Chief Executive Officer Pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
31.2
|
Certification by the Chief Financial Officer Pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
32.1‡
|
Certification by the Chief Executive Officer and the Chief Financial Officer Pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
101.INS‡
|
XBRL Instance Document
|
|||
|
101.SCH‡
|
XBRL Taxonomy Extension Schema Document
|
|||
|
101.CAL‡
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|||
|
101.DEF‡
|
XBRL Extension Definition
|
|||
|
101.LAB‡
|
XBRL Taxonomy Extension Label Linkbase Document
|
|||
|
101.PRE‡
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|||
|
|
|
|
|
|
|
|
DOLBY LABORATORIES, INC.
|
|
||
|
|
|
|
|
|
|
|
By:
|
|
/s/ Lewis Chew
|
|
|
|
|
|
Lewis Chew
|
|
|
|
|
|
Executive Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|